BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

34 filings reported holding BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share as of Q3 2025.
BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.29M shares of 37.4M outstanding shares and own 6.12% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (875K shares), Vestal Point Capital, LP (313K shares), RTW INVESTMENTS, LP (313K shares), Soleus Capital Management, L.P. (210K shares), EVENTIDE ASSET MANAGEMENT, LLC (195K shares), MARSHALL WACE, LLP (188K shares), PERCEPTIVE ADVISORS LLC (49.8K shares), MILLENNIUM MANAGEMENT LLC (20.7K shares), GEODE CAPITAL MANAGEMENT, LLC (15.6K shares), and STATE STREET CORP (13.3K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.